{"id":"W3015718611","doi":"10.1053/j.gastro.2020.04.012","title":"AGA Clinical Practice Update on Management of Inflammatory Bowel Disease During the COVID-19 Pandemic: Expert Commentary","year":2020,"lang":"en","type":"article","venue":"Gastroenterology","topic":"COVID-19 and healthcare impacts","field":"Medicine","cited_by":233,"is_retracted":false,"has_abstract":false,"ca_institutions":"","funders":"UCB Pharma; Genentech; Celgene; Janssen Pharmaceuticals; Gilead Sciences; Seres Therapeutics; GlaxoSmithKline; Osiris Therapeutics; Sanofi; Research and Development Corporation of Newfoundland and Labrador; Takeda Pharmaceuticals U.S.A.; Pfizer; Shire; Eli Lilly and Company; Bristol-Myers Squibb","keywords":"Coronavirus disease 2019 (COVID-19); Pandemic; Inflammatory bowel disease; Medicine; 2019-20 coronavirus outbreak; Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2); Intensive care medicine; Inflammatory Bowel Diseases; Disease; Clinical Practice; Virology; Internal medicine; Family medicine; Infectious disease (medical specialty); Outbreak","routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.009108088,0.001183018,0.00278335,0.002497921,0.00177705,0.004897085,0.003509212,0.02146664,0.01093435],"category_scores_gemma":[0.0764203,0.0008255619,0.00302489,0.002371843,0.002365742,0.005899709,0.003952183,0.02573561,0.005786012],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.004352566,"about_ca_system_score_gemma":0.01329535,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0128503,"about_ca_topic_score_gemma":0.0265834,"domain_scores_codex":[0.9874251,0.005772835,0.00223906,0.001046088,0.002779971,0.0007368958],"domain_scores_gemma":[0.9202977,0.04727883,0.006368471,0.0007789045,0.02016927,0.005106906],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0000524955,0.00002775761,0.0004466797,0.001804168,0.00009509452,0.000339699,0.0001377009,0.0001452543,0.00004972023,0.001628582,0.9552884,0.03998451],"study_design_scores_gemma":[0.000174391,0.00006273771,0.001441815,0.03652921,0.0002816435,0.0008508353,0.0005896454,0.0002362087,0.00008114164,0.006536968,0.9531182,0.00009703662],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","genre_codex":"commentary","genre_gemma":"editorial","genre_scores_codex":[0.0001978712,0.08082657,0.0004381561,0.8694986,0.04406341,0.00003480112,0.0003920884,0.00005087207,0.004497563],"genre_scores_gemma":[0.003874055,0.1171366,0.001823094,0.7324698,0.1421399,0.0001200934,0.0004920989,0.00004912881,0.001895153],"genre_candidate":"editorial","genre_consensus":null,"teacher_disagreement_score":0.02146664,"threshold_uncertainty_score":0.04816872,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.09912863441796235,"score_gpt":0.426381361536512,"score_spread":0.3272527271185497,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}